To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH	Hemic and Lymphatic Diseases, Histiocytosis, Langerhans-Cell, histiocytosis, interstitial lung disease, lung disorder, lymphatic system disorder, respiratory system disorder	Recruiting	Phase 2	2025-01-24		NCT05997602

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	24

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Children's Hospital, Capital Medical University	Beijing	China	6
Children's Hospital Affiliated to the Capital Institute of Pediatrics	Beijing	China	1
Children's Hospital of Chongqing Medical University	Chongqing	China	4
Children's Hospital of Soochow University	Suzhou	China	7
Children's Hospital, Zhejiang University School of Medicine	Hangzhou	China	8
Henan Children's Hospital Zhengzhou Children's Hospital	Zhengzhou	China	3
Shenzhen Children's Hospital	Shenzhen	China	4
Sun Yat-Sen Memorial Hpsipital,Sun Yat-Sen Unniversity	Guangzhou	China	1
The First Affiliated Hospital,Sun Yat-sen University	Guangzhou	China	3
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology	Wuhan	China	9
West China Second University Hospital,Sihuan University/West China women's and Children's Hospital	Chengdu	China	1